Titanium Alloy 3D-Printed Implants: A Rising Force in the Medical Field
In the era of rapid advancement in medical technology, metal 3D printing has revolutionized the development and production of implants. Among these, titanium alloys have secured a pivotal position in the field of 3D-printed implants due to their unique advantages, with applications flourishing both domestically and internationally. This dynamic progress has drawn widespread attention within the industry. Titanium Home has covered this development, bearing witness to the rise of titanium alloy 3D-printed implants in the medical field.
Titanium Alloy 3D-Printed Implants: Popular Abroad, Rising
Domestically overseas, metal 3D-printed implants—particularly those made of titanium alloy—have become widely adopted. Millions are implanted annually, offering hope for recovery to countless patients. Domestically, China is closing the gap with international leaders. Not only have manufacturers emerged with annual revenues exceeding 100 million yuan in metal 3D-printed implants, but the number of approved products is also steadily increasing. As noted by Titanium Home in its report, the rapid development of China's titanium alloy 3D-printed implant market reflects the nation's enhanced medical technology capabilities. It injects new vitality into the domestic medical device industry.
Huaxiang Medical and Huashu High-Tech: Collaborating to Achieve Multiple “Firsts in China.” The partnership between Huaxiang Medical and Huashu High-Tech stands as a model collaboration. Together, they have achieved multiple breakthroughs in the field of titanium alloy 3D-printed implants, propelling domestic medical 3D printing from technological exploration to large-scale clinical application.
2021: Filling a Domestic Technology Gap
In February 2021, leveraging Huashu High-Tech's metal additive manufacturing solutions, Huaxiang Medical's independently developed titanium alloy 3D-printed porous vertebral fusion device successfully obtained NMPA Class III medical device registration certification. This product holds significant importance. Not only does it represent Huaxiang Medical's first breakthrough in titanium alloy implants, but it also became China's first metal 3D-printed orthopedic implant to obtain a Class III medical device license. It filled the domestic technical and clinical application gap for titanium alloy 3D-printed vertebral fusion devices, laying a solid foundation for the development of China's orthopedic medical field.
2022: Ushering in a New Era of Spinal Treatment.
In February 2022, Huaxiang Medical's titanium alloy 3D-printed porous intervertebral fusion device was officially approved for market release by the NMPA. As China's first metal 3D printing (SLM)-based intervertebral fusion product series to gain approval, its launch marks the official entry of China's spinal fusion treatment into the new era of “laser-sintered titanium alloy implants,” offering patients with spinal conditions more advanced treatment options. This product's market entry not only elevates China's spinal treatment technology but also delivers superior patient experiences, propelling the nation's spinal healthcare toward precision and personalization.
2023: Expanding High-End Applications.
In 2023, Huaxiang Medical achieved significant progress in tantalum metal additive manufacturing, with two tantalum metal implants receiving approvals. The tantalum metal additive manufacturing intervertebral fusion device, approved in January, marks Huaxiang Medical's first tantalum metal orthopedic implant. Utilizing tantalum metal powder as its core material and Huashu High-Tech's laser selective melting 3D printing technology, this product creates a bionic trabecular implant with a three-dimensional interconnected structure. The porous tantalum hip joint filling block approved in November further expands the clinical applications of 3D-printed tantalum metal devices. Designed to address clinical needs such as hip replacement and bone defect repair, this product achieves dual upgrades in “precision” and “stability,” providing robust support for high-end medical applications.
2024: Precisely Addressing Niche Clinical Needs.
In 2024, Huaxiang Medical's titanium alloy implants continued their momentum with rapid market rollouts. In April, the company successfully obtained NMPA Class III medical device registration for its metal 3D-printed thoracolumbar porous vertebral fusion cage, submitted as a supplementary application. This product represents an upgraded supplement to the 2021 titanium alloy porous vertebral fusion cage, specifically engineered for the anatomical characteristics and clinical requirements of the thoracolumbar spine, further refining the company's product coverage in spinal fusion therapy. In May, the company's independently developed and manufactured 3D-printed bionic trabecular structure self-stabilizing cervical interbody fusion system became the first of its kind in China to gain NMPA approval for market launch. Utilizing titanium alloy as its core material, this system features a revolutionary design addressing pain points in traditional cervical fusion surgery. It significantly enhances surgical safety and the postoperative experience of patients while meeting specialized clinical needs.
2025: Adding Another “Powerful Tool” to the Portfolio.
In October 2025, Huaxiang Medical received NMPA approval for its new additive manufacturing titanium alloy intervertebral fusion device, developed using Huashu High-Tech's metal 3D printing solution, further expanding its 3D-printed spinal product line. This product can be used in conjunction with spinal internal fixation systems for intervertebral fusion procedures in the cervical spine (C2/3 - C7/T1) and thoracolumbar spine (T1/2 - L5/S1) (requiring bone grafting around the product). Leveraging the latest technological advancements, it offers a domestically produced option that better meets the needs of orthopedic clinical treatment. As noted in a report by Titanium Home, the launch of this product further solidifies Huaxiang Medical's leading position in China's titanium alloy 3D-printed spinal implant sector while injecting fresh momentum into the development of orthopedic medicine in the country.
Huashu High-Tech Medical-Grade Additive Manufacturing Solutions:
Empowering Precision Medicine Huashu High-Tech provides robust support for precision medicine through its medical-grade additive manufacturing solutions. These encompass the entire workflow—from 3D printing equipment, printing materials, and printing processes to product design, product inspection, and sterile production—with core technologies featuring fully independent intellectual property rights. Titanium Home provided an in-depth analysis of this solution in its coverage, highlighting its significant importance in advancing the standardization and large-scale development of medical 3D printing in China. Huashu High-Tech's medical-grade 3D printing equipment encompasses both metal and polymer models, having obtained Class I medical device registration. The equipment leverages open-source advantages, enabling users to independently adjust parameters and print different test groups for experiments, such as testing rod diameter and surface roughness. The equipment offers flexible build dimensions and printing efficiency that meet the demands of clinical emergency surgeries. The surface quality, mechanical properties, and dimensional accuracy of 3D-printed medical products all meet medical-grade standards.
Meeting Stringent Certification and Production Demands
For the rigorous certification requirements and high process continuity demands of Class III medical devices, the dual-chamber configuration solution of Huashu High-Tech's FS273M metal additive manufacturing equipment delivers outstanding performance. It enables medical users to flexibly switch between R&D and mass production modes without altering process parameters, effectively reducing material usage costs. Additionally, utilizing medical-grade powder materials with excellent biocompatibility, it offers a diverse range of printable materials, providing robust support for the R&D and production of various medical devices and implants. This solution addresses numerous challenges faced by medical users during R&D and production, offering strong backing for the large-scale production of domestically manufactured medical 3D printing products.
Titanium alloy 3D-printed implants hold vast application potential in the medical field due to their unique advantages and continuous technological innovation. The collaborative achievements between Huaxiang Medical and Huashu High-Tech demonstrate China's formidable capabilities and immense potential in this domain. Moving forward, titanium alloy 3D-printed implants are poised to deliver superior, more precise medical solutions to a growing number of patients, driving continuous advancement in China's medical technology standards.